Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04821622
Title	Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Recruitment	Active, not recruiting
Gender	male
Phase	Phase III
Variant Requirements	Yes
Sponsors	Pfizer
Indications	prostate cancer prostate adenocarcinoma
Therapies	Enzalutamide Enzalutamide + Talazoparib
Age Groups:	senior \| adult
Covered Countries	USA \| TUR \| SVK \| NOR \| NLD \| ITA \| HUN \| GBR \| FRA \| FIN \| ESP \| DEU \| CZE \| CAN \| BGR \| BEL \| AUS \| ARG